{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:58:34Z","timestamp":1780045114573,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous reports have shown an increased number of colorectal cancers in patients with cystic fibrosis. We assessed the database of our cystic fibrosis center to identify patients with all kinds of cancer retrospectively. All patients visiting the Cystic Fibrosis Centre Innsbruck between 1995 and 2019 were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Among 229 patients with cystic fibrosis treated at the Cystic Fibrosis Centre in Innsbruck between 1995 and 2019, 11 subjects were diagnosed with a malignant disease. The median age at diagnosis was 25.2\u00a0years (mean 24.3\u00a0years). There were four gynecological malignancies (cervical intraepithelial neoplasia and cervical cancer), two hematological malignancies (acute lymphocytic leukemia), one gastrointestinal malignancy (peritoneal mesothelioma), and four malignancies from other origins (malignant melanoma, neuroblastoma, adrenocortical carcinoma, and thyroid cancer). One malignancy occurred after lung transplantation. There was a strong preponderance of females, with 10 of the 11 cases occurring in women. Six deaths were attributed to cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Most diagnoses were made below 30\u00a0years of age, and half of the subjects died from the malignant disease. Awareness of a possible malignancy is needed in patients with atypical symptoms. Regular screenings for cancer should also be considered, not only for gastrointestinal tumors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-03234-1","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:03:19Z","timestamp":1642550599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Malignancies in patients with cystic fibrosis: a case series"],"prefix":"10.1186","volume":"16","author":[{"given":"Dorothea","family":"Appelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gratiana","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Ellemunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"issue":"2","key":"3234_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1753465810386051","volume":"5","author":"MD Parkins","year":"2011","unstructured":"Parkins MD, Parkins VM, Rendall JC, Elborn S. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Ther Adv Respir Dis. 2011;5(2):105\u201319.","journal-title":"Ther Adv Respir Dis"},{"issue":"5","key":"3234_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0022-3476(05)80296-3","volume":"119","author":"JP Neglia","year":"1991","unstructured":"Neglia JP, Wielinski CL, Warwick WJ. Cancer risk among patients with cystic fibrosis. J Pediatr. 1991;119(5):764\u20136.","journal-title":"J Pediatr"},{"issue":"12","key":"3234_CR3","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/ijc.24679","volume":"125","author":"M Johannesson","year":"2009","unstructured":"Johannesson M, Askling J, Montgomery SM, Ekbom A, Bahmanyar S. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer. 2009;125(12):2953\u20136.","journal-title":"Int J Cancer"},{"issue":"Suppl 27","key":"3234_CR4","first-page":"38","volume":"89","author":"MH Sch\u00f6ni","year":"1996","unstructured":"Sch\u00f6ni MH, Maisonneuve P, Sch\u00f6ni-Affolter F, Lowenfels AB. Cancer risk in patients with cystic fibrosis: the European data. CF\/CSG Group. J R Soc Med. 1996;89(Suppl 27):38\u201343.","journal-title":"J R Soc Med"},{"issue":"5","key":"3234_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jnci\/95.5.381","volume":"95","author":"P Maisonneuve","year":"2003","unstructured":"Maisonneuve P, FitzSimmons SC, Neglia JP, Campbell PW, Lowenfels AB. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst. 2003;95(5):381\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"3234_CR6","first-page":"90","volume":"35","author":"NE Hough","year":"2020","unstructured":"Hough NE, Chapman SJ, Flight WG. Gastrointestinal malignancy in cystic fibrosis. Paediatr Respir Rev. 2020;35:90\u20132.","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"3234_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djs481","volume":"105","author":"P Maisonneuve","year":"2013","unstructured":"Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst. 2013;105(2):122\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"3234_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199502233320803","volume":"332","author":"JP Neglia","year":"1995","unstructured":"Neglia JP, FitzSimmons SC, Maisonneuve P, Sch\u00f6ni MH, Sch\u00f6ni-Affolter F, Corey M, et\u00a0al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995;332(8):494\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"3234_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/bjc.1993.474","volume":"68","author":"CD Sheldon","year":"1993","unstructured":"Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ. A cohort study of cystic fibrosis and malignancy. Br J Cancer. 1993;68(5):1025\u20138.","journal-title":"Br J Cancer"},{"issue":"Suppl 2","key":"3234_CR10","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.jcf.2017.06.013","volume":"16","author":"JM Abraham","year":"2017","unstructured":"Abraham JM, Taylor CJ. Cystic fibrosis & disorders of the large intestine: DIOS, constipation, and colorectal cancer. J Cyst Fibros. 2017;16(Suppl 2):S40\u20139.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"3234_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11894-017-0546-0","volume":"19","author":"M Garg","year":"2017","unstructured":"Garg M, Ooi CY. The enigmatic gut in cystic fibrosis: linking inflammation, dysbiosis, and the increased risk of malignancy. Curr Gastroenterol Rep. 2017;19(2):6.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"3234_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jcf.2017.07.009","volume":"16","author":"M Hegagi","year":"2017","unstructured":"Hegagi M, Aaron SD, James P, Goel R, Chatterjee A. Increased prevalence of colonic adenomas in patients with cystic fibrosis. J Cyst Fibros. 2017;16(6):759\u201362.","journal-title":"J Cyst Fibros"},{"issue":"10","key":"3234_CR13","first-page":"310","volume":"99","author":"PB McKenna","year":"2006","unstructured":"McKenna PB, Mulcahy E, Waldron D. Early onset of colonic adenocarcinoma associated with cystic fibrosis\u2014a case report. Ir Med J. 2006;99(10):310\u20131.","journal-title":"Ir Med J"},{"issue":"5","key":"3234_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jcf.2011.05.003","volume":"10","author":"KC Meyer","year":"2011","unstructured":"Meyer KC, Francois ML, Thomas HK, Radford KL, Hawes DS, Mack TL, et\u00a0al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros. 2011;10(5):366\u20139.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"3234_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","volume":"19","author":"A Yamada","year":"2018","unstructured":"Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018;19(6):758\u201367.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3234_CR16","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et\u00a0al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"key":"3234_CR17","unstructured":"Zolin A, Orenti A, Naehrlich L, Jung A, van Rens J, et\u00a0al. ECFSPR Annual Report 2018; 2020."},{"issue":"3","key":"3234_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","volume":"154","author":"D Hadjiliadis","year":"2018","unstructured":"Hadjiliadis D, Khoruts A, Zauber AG, Hempstead SE, Maisonneuve P, Lowenfels AB. Cystic fibrosis colorectal cancer screening consensus recommendations. Gastroenterology. 2018;154(3):736-745.e14.","journal-title":"Gastroenterology"},{"key":"3234_CR19","unstructured":"Statistik Austria. \u00d6sterreichisches Krebsregister (Stand:17.12.2021) [cited 2021 Mar 22]. https:\/\/www.statistik.at."},{"issue":"5","key":"3234_CR20","first-page":"906","volume":"144","author":"EF Tizzano","year":"1994","unstructured":"Tizzano EF, Silver MM, Chitayat D, Benichou JC, Buchwald M. Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol. 1994;144(5):906\u201314.","journal-title":"Am J Pathol"},{"key":"3234_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejogrb.2017.12.005","volume":"221","author":"C Rousset-Jablonski","year":"2018","unstructured":"Rousset-Jablonski C, Reynaud Q, Nove-Josserand R, Ray-Coquard I, Mekki Y, Golfier F, et\u00a0al. High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis. Eur J Obstet Gynecol Reprod Biol. 2018;221:40\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"3234_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/IGC.0b013e318292da82","volume":"23","author":"Z Wu","year":"2013","unstructured":"Wu Z, Peng X, Li J, Zhang Y, Hu L. Constitutive activation of nuclear factor \u03baB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis. Int J Gynecol Cancer. 2013;23(5):906\u201315.","journal-title":"Int J Gynecol Cancer"},{"key":"3234_CR23","doi-asserted-by":"publisher","first-page":"966","DOI":"10.12659\/MSM.899341","volume":"23","author":"X Xia","year":"2017","unstructured":"Xia X, Wang J, Liu Y, Yue M. Lower cystic fibrosis transmembrane conductance regulator (CFTR) promotes the proliferation and migration of endometrial carcinoma. Med Sci Monit. 2017;23:966\u201374.","journal-title":"Med Sci Monit"},{"issue":"8","key":"3234_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/thorax.56.8.649","volume":"56","author":"FP Edenborough","year":"2001","unstructured":"Edenborough FP. Women with cystic fibrosis and their potential for reproduction. Thorax. 2001;56(8):649\u201355.","journal-title":"Thorax"},{"issue":"9","key":"3234_CR25","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.3390\/ijms21093133","volume":"21","author":"MD Amaral","year":"2020","unstructured":"Amaral MD, Quaresma MC, Pankonien I. What role does CFTR play in development, differentiation, regeneration and cancer? Int J Mol Sci. 2020;21(9):3133.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3234_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(18)30250-X","volume":"19","author":"M Slae","year":"2018","unstructured":"Slae M, Wilschanski M. Cystic fibrosis: a gastrointestinal cancer syndrome. Lancet Oncol. 2018;19(6):719\u201320.","journal-title":"Lancet Oncol"},{"issue":"22","key":"3234_CR27","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1001\/archinternmed.2009.440","volume":"169","author":"BA de Gonz\u00e1lez","year":"2009","unstructured":"de Gonz\u00e1lez BA, Mahesh M, Kim K-P, Bhargavan M, Lewis R, Mettler F, et\u00a0al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169(22):2071\u20137.","journal-title":"Arch Intern Med"},{"key":"3234_CR28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jmri.27030","volume":"52","author":"JC Woods","year":"2019","unstructured":"Woods JC, Wild JM, Wielp\u00fctz MO, Clancy JP, Hatabu H, Kauczor H-U, et\u00a0al. Current state of the art MRI for the longitudinal assessment of cystic fibrosis. J Magn Reson Imag. 2019;52:1306\u201320.","journal-title":"J Magn Reson Imag"},{"key":"3234_CR29","doi-asserted-by":"crossref","unstructured":"Naselli A, Cresta F, Favilli F, Casciaro R. A long-term follow-up of residual mass neuroblastoma in a patient with cystic fibrosis. BMJ Case Rep 2015; 2015.","DOI":"10.1136\/bcr-2014-205284"},{"issue":"5","key":"3234_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1542\/peds.76.5.814","volume":"76","author":"RB Moss","year":"1985","unstructured":"Moss RB, Blessing-Moore J, Bender SW, Weibel A. Cystic fibrosis and neuroblastoma. Pediatrics. 1985;76(5):814\u20137.","journal-title":"Pediatrics"},{"issue":"5","key":"3234_CR31","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/or.2015.3829","volume":"33","author":"J Xu","year":"2015","unstructured":"Xu J, Yong M, Li J, Dong X, Yu T, Fu X, et\u00a0al. High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo. Oncol Rep. 2015;33(5):2227\u201334.","journal-title":"Oncol Rep"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03234-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:03:25Z","timestamp":1642550605000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3234"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03234-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's legal guardian or next of kin for publication of this case report. A copy of the written consent is available for review\u00a0by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}